BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/28/2021 1:52:02 AM | Browse: 353 | Download: 715
 |
Received |
|
2021-04-02 10:57 |
|
Peer-Review Started |
|
2021-04-02 11:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-28 03:05 |
|
Revised |
|
2021-05-16 13:13 |
|
Second Decision |
|
2021-06-01 12:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-06-01 13:13 |
|
Articles in Press |
|
2021-06-01 13:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-06-08 21:38 |
|
Typeset the Manuscript |
|
2021-07-23 08:29 |
|
Publish the Manuscript Online |
|
2021-07-28 01:52 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Primary small cell esophageal carcinoma, chemotherapy sequential immunotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Hui Wu, Kai Zhang, Hui-Guo Chen, Wei-Bin Wu, Xiao-Jun Li and Jian Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jian Zhang, PhD, Assistant Professor, Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Guangzhou 510630, Guangdong Province, China. sumszhangjian@163.com |
| Key Words |
Primary small cell esophageal carcinoma; Diagnosis; Chemotherapy; Immunotherapy; Case report |
| Core Tip |
A 79-year-old male was diagnosed primary small cell esophageal carcinoma and multiple lymph nodes metastasis thorough computed tomography, positron emission tomography-computed tomography, endoscopy and pathology. Surgery wasn’t suitable for this patient. He was treated with etoposide and cisplatin chemotherapy regiment, every 3 wk, 4 cycles. The tumor and lymph nodes become smaller than the first imaging exam. The patient can’t tolerate subsequent chemotherapy because of hematological toxicity, we performed immunotherapy (Durvalumab 1500 mg) every 4 wk for sequential therapy, at present the patient had received 12 cycles immunotherapy about 1 year and still continued to treatment and follow-up. |
| Publish Date |
2021-07-28 01:52 |
| Citation |
Wu YH, Zhang K, Chen HG, Wu WB, Li XJ, Zhang J. Primary small cell esophageal carcinoma, chemotherapy sequential immunotherapy: A case report. World J Clin Cases 2021; 9(22): 6478-6484 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i22/6478.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i22.6478 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
